Peer-influenced content. Sources you trust. No registration required. This is HCN.

Medical News Today (MNT)High-fiber Diet vs Metformin: Which is Better for Blood Sugar Control, Weight Loss?

⚠️ Small Study / Early Comparative Evidence

Researchers randomized 48 adults with recently diagnosed type 2 diabetes and overweight or obesity to a prescribed high-fiber dietary intervention without medication or metformin alone for 84 days. At follow-up, the dietary group had lower baseline-adjusted mean BMI and HbA1c than the metformin group, alongside changes in gut microbial composition. The findings provide an early comparative signal, but the small cohort, short follow-up, and intensive dietary intervention limit conclusions about replacing established pharmacotherapy.


Clinical Considerations

  • The high-fiber group showed lower baseline-adjusted BMI and HbA1c at day 84 compared with participants receiving metformin alone.
  • Microbiome changes included increases in Bifidobacterium and Lactobacillus and reduced Bilophila wadsworthia by day 28.
  • The dietary intervention involved prescribed fiber products plus dietary guidance, making the findings difficult to extrapolate to routine advice to “eat more fiber.”
  • With only 48 total participants, the trial provides limited precision and cannot establish comparative effectiveness across broader type 2 diabetes populations.
  • Follow-up lasted 84 days, leaving durability of glycemic, weight, and microbiome changes uncertain.
  • The findings do not establish that dietary fiber should replace metformin or other guideline-directed treatment.

Practice Applications

  • Interpret the findings as an early clinical signal supporting further study of structured high-fiber interventions in type 2 diabetes and obesity.
  • Avoid presenting the study as evidence that patients should substitute dietary intervention for prescribed metformin.
  • Recognize that the tested intervention appears more structured than general dietary counseling, limiting extrapolation to routine food choices.
  • Monitor larger and longer comparative trials for durability, safety, adherence, and clinically meaningful metabolic outcomes.
The Healthcare Communications Network is owned and operated by IQVIA Inc.

Click below to leave this site and continue to IQVIA’s Privacy Choices form